Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1976-08-25
1978-08-22
Padgett, Benjamin R.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
23230B, 260112R, G01N 3316, A61K 4300
Patent
active
041089731
ABSTRACT:
Epinephrine and norepinephrine type catecholamines can be individually assayed by immunoassay directed against the side chain common to these compounds by employing an oxidation procedure which selectively converts one or more of the epinephrine or norepinephrine type catecholamines to another compound which is not bound by the antibody. By measuring the difference between the total epinephrine or norepinephrine type catecholamine content and that after each of the oxidation steps, it is possible to determine the quantity of individual catecholamines of either type present in the original sample.
REFERENCES:
patent: 3704282 (1972-11-01), Spector
patent: 3878187 (1975-04-01), Schneider et al.
patent: 3996344 (1976-12-01), Gross
patent: 4016146 (1977-04-01), Soares
Avenia Richard William
Pecherer Benjamin
Gould George M.
Hoffmann-La Roche Inc.
Nucker Christine M.
Padgett Benjamin R.
Welt Samuel L.
LandOfFree
Immunoassay for catecholamines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunoassay for catecholamines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunoassay for catecholamines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1558432